Michael L van de Weijer (M L Van de Weijer, Michael Van de Weijer)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Postmenopausal Women

Breast Cancer Cells

Dna Methylation

Endoplasmic Reticulum

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Tom Cremer, Hanneke Hoelen, Michael L van de Weijer, George M Janssen, Ana I Costa, Peter A van Veelen, Robert Jan Lebbink, Emmanuel J H J Wiertz
Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2. PloS one 19 (5) (2024)
Tom Cremer, Hanneke Hoelen, Michael L van de Weijer, George M Janssen, Ana I Costa, Peter A van Veelen, Robert Jan Lebbink, Emmanuel J H J Wiertz
Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2. PloS one 19 (5) (2024)
Logesvaran Krshnan, Wingyan Skyla Siu, Michael L van de Weijer, Daniel Hayward, Elena Navarro Guerrero, Ulrike Gruneberg, Pedro Carvalho
Regulated degradation of the inner nuclear membrane protein SUN2 maintains nuclear envelope architecture and function. eLife 11 (2022)
A B C Schuren, I G J Boer, E M Bouma, Michael L van de Weijer, A I Costa, P Hubel, A Pichlmair, Robert Jan Lebbink, Emmanuel J H J Wiertz
The UFM1 Pathway Impacts HCMV US2-Mediated Degradation of HLA Class I. Molecules (Basel, Switzerland) 26 (2) (2021)